Janux Therapeutics

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell JANX and other ETFs, options, and stocks.

About JANX

Janux Therapeutics, Inc. operates a preclinical stage biopharmaceutical company which engages in developing therapeutics based on the Tumor Activated T Cell Engager platform technology. The company was founded in June 2017 and is headquartered in San Diego, CA.

CEO

David Campbell

CEODavid Campbell

Employees

Employees33

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

2017

Founded2017

Employees

Employees33

JANX Key Statistics

Market cap

634.50M

Market cap634.50M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

62.52K

Average volume62.52K

High today

$15.39

High today$15.39

Low today

$13.72

Low today$13.72

Open price

$13.72

Open price$13.72

Volume

69.07K

Volume69.07K

52 Week high

$22.61

52 Week high$22.61

52 Week low

$9.39

52 Week low$9.39

JANX Earnings

-$0.62

-$0.41

-$0.21

$0.00

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Q4 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Mar 17, After Hours

ActualExpected Mar 17, After Hours

Janux Therapeutics

Why Robinhood?

Janux Therapeutics, Inc. operates a preclinical stage biopharmaceutical company which engages in developing therapeutics based on the Tumor Activated T Cell Engager platform technology. The company was founded in June 2017 and is headquartered in San Diego, CA. Show more

JANX Key Statistics

Janux Therapeutics, Inc. operates a preclinical stage biopharmaceutical company which engages in developing therapeutics based on the Tumor Activated T Cell Engager platform technology. The company was founded in June 2017 and is headquartered in San Diego, CA.